Suchergebnisse - Ana Florea

Risk of herpes zoster following mRNA COVID-19 vaccine administration von Ana Florea, Jun Wu, Lei Qian, Bruno Lewin, Lina S. Sy, I-Chun Lin, Jennifer H. Ku, Hung Fu Tseng

Connect to this object online.

Real-world effectiveness of the mRNA-1273 vaccine against COVID-19: Interim results from a prospective observational cohort study von Katia J. Bruxvoort, Lina S. Sy, Lei Qian, Bradley K. Ackerson, Yi Luo, Gina S. Lee, Yun Tian, Ana Florea, Harpreet S. Takhar, Julia E. Tubert, Carla A. Talarico, Hung Fu Tseng

Connect to this object online.

Real-world effectiveness of recombinant zoster vaccine in self-identified Chinese individuals aged ≥50 years in the United States von Ana Florea, Lina Sy, Lei Qian, Bradley Ackerson, Yi Luo, Jun Wu, Yanjun Cheng, Jennifer Ku, Leticia Vega Daily, Harpreet Takhar, Jeannie Song, Elizabeth Chmielewski-Yee, O'Mareen Spence, Harry Seifert, Driss Oraichi, Hung Fu Tseng

Connect to this object online.

Effectiveness and durability of mRNA-1273 BA.4/BA.5 bivalent vaccine (mRNA-1273.222) against SARS-CoV-2 BA.4/BA.5 and XBB sublineages von Bradley K. Ackerson, Katia J. Bruxvoort, Lei Qian, Lina S. Sy, Sijia Qiu, Julia E. Tubert, Gina S. Lee, Jennifer H. Ku, Ana Florea, Yi Luo, Radha Bathala, Julie Stern, Soon K. Choi, Harpreet S. Takhar, Michael Aragones, Morgan A. Marks, Evan J. Anderson, Cindy Ke Zhou, Tianyu Sun, Carla A. Talarico, Hung Fu Tseng

Connect to this object online.